Does ADALIMUMAB Cause C-reactive protein abnormal? 3,629 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,629 reports of C-reactive protein abnormal have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.7% of all adverse event reports for ADALIMUMAB.
3,629
Reports of C-reactive protein abnormal with ADALIMUMAB
0.7%
of all ADALIMUMAB reports
1,162
Deaths
2,159
Hospitalizations
How Dangerous Is C-reactive protein abnormal From ADALIMUMAB?
Of the 3,629 reports, 1,162 (32.0%) resulted in death, 2,159 (59.5%) required hospitalization, and 1,361 (37.5%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 3,629 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
TOFACITINIB (2,062)
Which ADALIMUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB